Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2017

View Archived Issues

ProMIS Neurosciences selects third lead product for Alzheimer's disease

TLD-1633 demonstrates increased efficacy in glioblastoma multiforme cell line

Phase II results presented for tezepelumab in adults with uncontrolled asthma

First data on AZD-7594 in asthma patients disclosed

Daiichi Sankyo and MD Anderson enter AML research collaboration

Halozyme Therapeutics licenses its Enhanze drug-delivery technology to Roche

Collaborations Pharmaceuticals receives NIH award to repurpose drug for Chagas disease

Nemiralisib delivered via ELLIPTA device found to be safe and well tolerated

Harvard's Wyss Institute launches human Organ Chip project

Independent DMC recommends discontinuation of Prostvac phase III study in mCRPC

FDA approves Aliqopa for relapsed follicular lymphoma

Briviact monotherapy approved in U.S. for partial-onset seizures in adults

RDD Pharma wins grant to test RDD-0315 for fecal incontinence in SCI patients

Janssen files sNDA for Zytiga for earlier stages of metastatic prostate cancer

NovoBiotic Pharmaceuticals patents novel macrocyclic antibiotics

FDA expands indication for Sunovion's Aptiom

Bristol-Myers Squibb and Halozyme announce agreement to use Enhanze technology in immuno-oncology

Shenzhen Targetrx Biotechnology discloses IDO inhibitors

FDA grants expanded approval to Afluria Quadrivalent influenza vaccine

RET inhibitors disclosed in GlaxoSmithKline patent

EMA committee recommends approval of Trelegy Ellipta for COPD

Phase III PROSPER study in patients with nonmetastatic CRPC meets primary endpoint

Alios BioPharma presents FXR agonists for NASH

ALK-Abello reports data from phase III study of tree allergy SLIT tablets

Bayer Pharma divulges BRD4 inhibitors for cancer

FDA approves bevacizumab biosimilar Mvasi

Celgene studies CC-90010 in advanced solid tumors and relapsed or refractory NHL

MEDI-4166 shows safety in type 2 diabetes subjects

FDA approves Privigen to treat chronic inflammatory demyelinating polyneuropathy in adults

Da Volterra and Bioaster present beta-lactamase variants

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 16, 2026.
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...